The injury that finally made this click for a lot of women is a tendon problem that appeared out of nowhere — no new sport, no sudden increase in training load, nothing obvious changed. It took connecting the dots between the timing and the hormonal shift to realise the tissue itself had changed, not the training. That realisation is frustrating but also genuinely useful, because it points toward solutions that actually work.
Learn more about Rose →Connective tissue is not a passive bystander to hormonal change — tendon fibroblasts and ligament cells carry estrogen receptors (predominantly ERα and ERβ), meaning they respond directly to circulating estrogen levels. When estrogen falls during perimenopause and menopause, these receptors lose their primary signal, and the cells begin to behave differently at a molecular level. This is the foundational reason why connective tissue vulnerability at menopause is a physiological phenomenon, not a coincidence or a fitness problem.
Estrogen actively upregulates the genes responsible for type I collagen production — the dominant structural protein in tendons and ligaments. Studies measuring skin collagen (a reliable proxy for musculoskeletal collagen) show a loss of approximately 30% in the first five years after menopause, with roughly 2% lost per postmenopausal year thereafter. Less collagen means less tensile strength: the tissue can store and release force less efficiently and is more susceptible to micro-tears under repetitive load.
Healthy tendons need a degree of stiffness to transfer muscular force to bone efficiently; too much compliance and energy leaks out of the system, increasing strain on the tendon itself. Estrogen withdrawal reduces tendon stiffness measurably — ultrasound elastography studies show postmenopausal women have significantly more compliant Achilles and patellar tendons than premenopausal age-matched peers. This change shifts mechanical stress to regions of the tendon less equipped to handle it, which is one reason tendinopathy tends to cluster at predictable sites.
While tendons connect muscle to bone, ligaments hold joints together — and they rely on estrogen to maintain appropriate tension. Research on the anterior cruciate ligament (ACL) has shown that estrogen modulates ligament laxity across the menstrual cycle, and postmenopausal women demonstrate increased knee and ankle ligament laxity compared to premenopausal women. Greater laxity means joints are less mechanically stable, which raises the risk of sprains, partial tears, and the kind of repetitive micro-instability that feeds chronic joint pain.
Estrogen has well-documented anti-inflammatory properties, partly through its modulation of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α. In tendons and ligaments, this means estrogen normally helps keep the low-grade inflammation that follows exercise or minor strain from becoming chronic. Without it, the resolution phase of connective tissue inflammation is impaired — a key reason why tendinopathies in perimenopausal and postmenopausal women often feel disproportionately persistent relative to the apparent cause.
Tenocytes (the cells that maintain tendon structure) regulate the balance between matrix metalloproteinases (MMPs, which break down collagen) and their inhibitors (TIMPs). Estrogen favours the inhibitory side of this equation, protecting existing collagen matrix. When estrogen falls, MMP activity increases relative to TIMP activity, tipping the balance toward net collagen degradation. The result is tissue that is being broken down faster than it is rebuilt — even in women who are training consistently and eating adequate protein.
Estrogen also influences skeletal muscle — it supports satellite cell activity, reduces exercise-induced muscle damage, and helps maintain fast-twitch fibre function. As estrogen declines, muscles may generate force less predictably and recover more slowly, which means tendons intermittently absorb loads they are not mechanically prepared for in a given session. This mismatch between muscle output and tendon readiness is a recognised injury mechanism in sports medicine, and menopause creates it chronically rather than acutely.
Connective tissue remodelling is heavily dependent on growth hormone, which is secreted predominantly during deep slow-wave sleep. The sleep disruption that affects a large proportion of perimenopausal and menopausal women — driven by night sweats, cortisol dysregulation, and altered sleep architecture — directly shortens and fragments this repair window. Tendons stressed during the day that would normally consolidate repairs overnight are instead left in a partially degraded state, compounding the structural changes driven by estrogen loss itself.
Because most sports medicine and physiotherapy training frames tendon injury as a load-management problem, practitioners often focus exclusively on training volume when a menopausal woman presents with persistent tendinopathy — cycling through loading protocols that produce incomplete results. The hormonal context changes what optimal management looks like: some women find that addressing estrogen levels through HRT significantly improves connective tissue response to the same rehabilitation exercises that previously stalled. Raising the hormonal picture with a clinician who understands it is a legitimate and evidence-informed part of the conversation.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.